Ex vivo tumor culture systems for functional drug testing and therapy response prediction

por Meijer, Titia G, Naipal, Kishan AT, Jager, Agnes, van Gent, Dik C
Publicado 2017

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?

por Beukers, Willemien, Meijer, Titia, Vissers, Cornelis J., Boormans, Joost L., Zwarthoff, Ellen C., van Leenders, Geert J. L. H.
Publicado 2012

Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response

por Zhang, Wenhao, van Weerden, Wytske M., de Ridder, Corrina M. A., Erkens‐Schulze, Sigrun, Schönfeld, Edgar, Meijer, Titia G., Kanaar, Roland, van Gent, Dik C., Nonnekens, Julie
Publicado 2018

Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer

por Ladan, Marjolijn M., Meijer, Titia G., Verkaik, Nicole S., Komar, Zofia M., van Deurzen, Carolien H. M., den Bakker, Michael A., Kanaar, Roland, van Gent, Dik C., Jager, Agnes
Publicado 2022

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients

por Ladan, Marjolijn M., Meijer, Titia G., Verkaik, Nicole S., de Monye, Cecile, Koppert, Linetta B., Oomen-de Hoop, Esther, van Deurzen, Carolien H. M., Kanaar, Roland, Nonnekens, Julie, van Gent, Dik C., Jager, Agnes
Publicado 2023

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests

por Meijer, Titia G., Nguyen, Luan, Van Hoeck, Arne, Sieuwerts, Anieta M., Verkaik, Nicole S., Ladan, Marjolijn M., Ruigrok-Ritstier, Kirsten, van Deurzen, Carolien H. M., van de Werken, Harmen J. G., Lips, Esther H., Linn, Sabine C., Memari, Yasin, Davies, Helen, Nik-Zainal, Serena, Kanaar, Roland, Martens, John W. M., Cuppen, Edwin, Jager, Agnes, van Gent, Dik C.
Publicado 2022